Chri Davis Journey of CML and its treatment with Dasatinib 50mg Tablet
This blog shares the inspiring recovery journey of Chris Davis, a CML (Chronic Myeloid Leukemia) survivor who battled both cancer and a heart attack. His treatment began with Imatinib (Glivec), followed by Dasatinib 50mg (Sprycel) and later Nilotinib (Tasigna)—all tyrosine kinase inhibitors (TKIs) that helped him achieve complete remission. The story highlights the challenges, treatment transitions, and ultimate success through timely diagnosis and effective medication. Affordable TKI medicines like Imatinib, Dasatinib, and Nilotinib are available at Magicine Pharma with global delivery.
“It’s like I’ve had three lives. There’s the life I used to have before CML, my life on drugs that I have no memory of, and now, when I have another chance at life and it’s utterly brilliant".- Chris Davis
CML stands for Chronic Myelogenous Leukemia. It is a type of blood cancer. It refers to uncontrolled growth and proliferation of white blood cells that begins in bone marrow and can accumulate in blood and spleen.
Overview of Chris's Life
Meet Chris Davis , a 69 years old man who regularly rode 100km on his bike, had taken up rowing again, and was about to reach 30 years of operating his own trucking business.He discovered about CML accidently.
Chris's Unexpected CML Diagnosis
In April 2005, he started feeling a bit low on energy. He experienced extreme pain in his shoulder and back when any pressure was exerted on his body by himself.
After some time, they found his daughter with haemochromatosis disease. After listening to this, he also had blood tests to detect iron load blood disorder just like his daughter. But the results came back negative; instead, he found out that he had a higher amount of white blood cells in his body and had CML.
After his initial diagnosis, he paid visit to a hematologist addressing his issues of continuous pain, only to discover that he was on a end line to get a massive heart attack.
Chris's Treatment with Targeted Therapy
His treatment team delayed his treatment for about one week due to a heart attack issue. In September 2005, the doctor prescribed him the first generation tyrosine kinase inhibitor (TKI), imatinib by Glivec. Due to this, he experienced several side effects including eye problems, extreme sun sensitivity, nausea,fatigue and problems with walking. With this medication, doctors observed a significant decrease in white blood cells post tests, which was a positive indication. He also found that this medication is harming his liver to a great extent and therefore, after 18 months, he had to go off this drug.
After six months, he again found out that CML is returning back and needs another effective medication.
This time, the doctor prescribed him second generation TKI, Dasatinib 50mg Tabletand other medication Sprycel for 4 months. As a result, the BCR-ABL count reached zero and stayed at that level.
In October 2008, he again changed his medication to nilotinib byTasigna. He took it consistently for about 4 and a half years until he took part in clinical trials for deep molecular response to TKI.
After trials, in the month of August He was given all clear.
Time passed by and till year 2013, he is not consuming any other medication for the same.
Conclusion
Treatment of CML has been a tough journey for Chris Davis. He not only defeated CML but also heart attack. His accidental timely diagnosis and effective treatment with TKIs medication had made a huge positive impact on his recovery path. To get huge discount and affordable deals on imatinib,Dasatinib Tablet Price and nilotinib, visit Magicine Pharma. It offers global delivery from verified sources.
Source: https://www.leukaemia.org.au/stories/heart-attack-and-cml/